March 21, 2025

RNA Origami: Artificial Cytoskeletons to Build Synthetic Cells

RNA Origami: Artificial Cytoskeletons to Build Synthetic Cells

Synthetic biologists from Heidelberg University create nanotubes folded from the natural RNA biomolecule

A cell-sized lipid vesicle (blue) is deformed based on the cytoskeletons from RNA origami (yellow). | © Mai Tran und Taniya Chakraborty

With the long-term goal of creating living cells from non-living components, scientists in the field of synthetic biology work with RNA origami. This tool uses the multifunctionality of the natural RNA biomolecule to fold new building blocks, making protein synthesis superfluous. In pursuit of the artificial cell, a research team led by Prof. Dr Kerstin Göpfrich at the Center for Molecular Biology of Heidelberg University has cleared a crucial hurdle. Using the new RNA origami technique, they succeeded in producing nanotubes that fold into cytoskeleton-like structures. The cytoskeleton is an essential structural component in cells that gives them stability, shape, and mobility. The research work forms the potential basis for more complex RNA machinery.

One major challenge in constructing synthetic cells is manufacturing proteins, which are responsible for nearly all biological processes in the organism and thus make life possible in the first place. For natural cells, the so-called central dogma of molecular biology describes how protein synthesis occurs through transcription and translation of genetic information in the cell. In the process, DNA is transcribed into RNA and then translated into functional proteins that subsequently undergo folding to achieve their correct structure, which is key to proper function. “There are over 150 genes involved in this complex process alone,” explains Prof. Göpfrich, who along with her team, “Biophysical Engineering of Life”, conducts research at the Center for Molecular Biology of Heidelberg University (ZMBH).

Prof. Göpfrich’s work starts with the question of how synthetic cells can be created that bypass protein synthesis, which is essential in living cells. She uses the technique of RNA origami, which is based on the idea that genetic information – the blueprint for the cell structure, for example – is translated using self-folding RNA alone. First, a DNA sequence is designed in a computer-assisted process. It codes for the shape that the RNA should assume after folding. To approximate the desired structure, suitable RNA motifs must be selected and translated into a genetic template that is ultimately synthesized as an artificial gene. To implement the blueprint it contains, RNA polymerase is used. The enzyme reads the information stored in the template and makes the corresponding RNA component. Algorithms specifically developed previously ensure that the planned folding occurs correctly.

The production of cytoskeletons from RNA origami: A polymerase reads the DNA template and produces an RNA thread that folds into the desired shape. After their production, the subunits are stored together based on specific interactions and form filaments. | © Matthew Clarke

Aided by RNA origami, the Heidelberg synthetic biologist and her team succeeded in creating an essential structural component of synthetic cells – an artificial cytoskeleton. The RNA microtubes, which are just a few microns in length, form a network that resembles a natural cell structure. According to Prof. Göpfrich, the nanotubes are another step toward building synthetic cells. The researchers tested the RNA origami in a lipid vesicle, a simple cell model system widely used in biology. Using so-called RNA aptamers, the artificial cytoskeleton was bound to the cell  membranes. Through targeted mutations to the genetic template – the DNA sequence – it was also possible to influence the properties of the RNA skeleton.

“In contrast to DNA origami, the advantage of RNA origami is that synthetic cells can manufacture their building blocks by themselves,” stresses Kerstin Göpfrich. She adds that this could open new perspectives on the directed evolution of such cells. The long-term research goal is creating a complete molecular machinery for RNA-based synthetic cells.

The current research was part of an ERC Starting Grant for Prof. Göpfrich from the European Research Council. Funding was also provided by the Human Frontier Science Program, the Federal Ministry of Education and Research, the Baden-Württemberg Ministry of Science within the framework of the Excellence Strategy of the German federal and state governments, and the Alfried Krupp Prize. The research results were published in the journal “Nature Nanotechnology”.

You are currently viewing a placeholder content from YouTube. To access the actual content, click the button below. Please note that doing so will share data with third-party providers.

More Information

Original publication

M. P. Tran, T. Chakraborty, E. Poppleton, L. Monari, M. Illig, F. Giessler, K. Göpfrich: Genetic encoding and expression of RNA origami cytoskeletons in synthetic cells. Nature Nanotechnology (17 March 2025)

Our latest News

discover more
Cardiac Arrhythmias: New Defibrillator System Expands Treatment Options at UKHD

Cardiac Arrhythmias: New Defibrillator System Expands Treatment Options at UKHD

At Heidelberg University Hospital (UKHD), there is a new treatment option for certain patients with severe cardiac arrhythmias: an implantable defibrillator in which the electrode—unlike in conventional defibrillators—is placed outside the heart and blood vessels. This protects the blood vessels. In addition, the system can correct some arrhythmias using mild electrical impulses before an electric […]

The Individual Genetic Background Shapes the Evolution of Cancer

The Individual Genetic Background Shapes the Evolution of Cancer

Why do cancers develop differently in different people—even when they are exposed to the same risk factors? An international research group, including the German Cancer Research Center (DKFZ), has now demonstrated in mice that an organism’s genetic makeup significantly influences the course of cancer development. The findings, now published in Nature, provide new insights into […]

Cell Signaling Technology Announces ISO 13485 Certification

Cell Signaling Technology Announces ISO 13485 Certification

Certification enables increased support for partners and customers with industry-leading antibody reagents for commercial applications. Danvers, MA, USA, July 16, 2026–Cell Signaling Technology (CST), a life science discovery technology company and leading provider of antibodies, kits, and services, today announced that its Beverly, MA, US and Leiden, NL facilities have achieved ISO 13485:2016 certification for […]

GET IN TOUCH

Stay Updated with bioRN’s Newsletter

Sign up for our newsletter to discover more!
* required

BioRN (BioRN Network e.V. and BioRN Cluster Management GmbH) will use the information you provide on this form to be in touch with you and to provide updates and marketing. Please let us know all the ways you would like to hear from us:

You can update your subscription preferences or unsubscribe at any time. Just follow the unsubscribe or update link in the footer of automated emails you receive from us, or by contacting us at info@biorn.org. We will treat your information with respect. For more information about our privacy practices please visit our website: www.biorn.org. By clicking below, you agree that we may process your information in accordance with these terms.

We use Mailchimp as our marketing platform. By clicking below to subscribe, you acknowledge that your information will be transferred to Mailchimp for processing. Learn more about Mailchimp's privacy practices.

Intuit Mailchimp